CopyPastehas never been so tasty!

Traumatic Brain Injury Partnering 2007-2012

by anonymous

  • 0
  • 0
  • 0
64 views


Summary

The Traumatic Brain Injury Partnering 2007-2012 report provides understanding and access to the traumatic brain injury partnering deals and agreements entered into by the worlds leading healthcare companies. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/traumatic-brain-injury-partnering-2007-2012.html

Trends in traumatic brain injury partnering deals
Top traumatic brain injury deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type
Description

The Traumatic Brain Injury Partnering 2007-2012 provides understanding and access to the traumatic brain injury partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of traumatic brain injury partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors traumatic brain injury technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 40 links to online copies of actual traumatic brain injury deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of traumatic brain injury partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in traumatic brain injury partnering since 2007, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.

Chapter 3 provides an overview of the leading traumatic brain injury deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive directory of traumatic brain injury partnering deals signed and announced since 2007. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the
research, development and commercialization of traumatic brain injury technologies and products.

Report scope

Traumatic Brain Injury Partnering 2007-2012 is intended to provide the reader with an in-depth understanding and access to traumatic brain injury trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

Trends in traumatic brain injury dealmaking in the biopharma industry since 2007
Access to summary headline, upfront, milestone and royalty data
The leading traumatic brain injury deals by value since 2007
In Traumatic Brain Injury Partnering 2007-2012, the available deals are listed by:

Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Benefits

Traumatic Brain Injury Partnering 2007-2012 provides the reader with the following key benefits:

In-depth understanding of traumatic brain injury deal trends since 2007
Access to summary headline, upfront, milestone and royalty data
Comprehensive access to over 40 actual traumatic brain injury deals entered into by the world’s biopharma companies since 2007
Insight into key deal terms included in contracts, where disclosed
Understand the key deal terms companies have agreed in deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in traumatic brain injury partnering
2.1. Introduction
2.2. Traumatic brain injury partnering over the years
2.3. Bigpharma traumatic brain injury dealmaking activity
2.4. Traumatic brain injury partnering by deal type
2.5. Traumatic brain injury partnering industry sector
2.6. Traumatic brain injury partnering by stage of development
2.7. Traumatic brain injury partnering by technology type
2.8. Disclosed financial deal terms for traumatic brain injury partnering
2.8.1 Traumatic brain injury headline values
2.8.2 Traumatic brain injury upfront payments
2.8.3 Traumatic brain injury milestone payments
2.8.4 Traumatic brain injury royalty rates

Chapter 3 – Leading traumatic brain injury deals
3.1. Introduction
3.2. Top traumatic brain injury deals by value
3.3. Top traumatic brain injury deals involving bigpharma

Chapter 4 – Dealmaking directory
4.1. Introduction
4.2. Company A-Z
4.3. By deal type
Asset purchase
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Contract service
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Manufacturing
Marketing
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Termination
4.4. By industry sector
Academic
Bigpharma
Biotech
Drug delivery
Medical device
Diagnostic
Generic pharma
Government
Non-profit
Pharmaceutical
Research tools
Services
Specialty pharma
4.5. By stage of development
Discovery
Pre-clinical
Phase I
Phase II
Phase III
Registration
Marketed
4.6. By technology type
Analysis
Animal models
Assays
Bioinformatics
Biological compounds
Biomarkers
Biomaterials
Cell culture
Cell therapy
Clinical testing
Diagnostic - companion
Devices
Diagnostics
Discovery tools
DNA probes
Drug delivery
Enabling technology
Epigenetics
Equipment
Facilities
Gene therapy
Genomics
Imaging
Industrial chemicals
In vitro models
Monoclonal antibodies
Nanotechnology
Oligonucleotide
Peptides
Personalised medicine
Processes
Proteomics
Radio/Chemo-therapy
Recombinant DNA
Research services
Research supplies
RNA therapeutics
Screening
Small molecules
Stem cells
Vaccines

For more information kindly visit :
Traumatic Brain Injury Partnering 2007-2012

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: https://twitter.com/BharatBook
Our Blogs: http://in.linkedin.com/pub/bharat-book/3a/98/512
http://financemarketreports.blogspot.com/

Add A Comment: